The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 30, 2019
Filed:
Sep. 25, 2018
Applicant:
Vactronix Scientific, Llc, Fremont, CA (US);
Inventors:
Julio C. Palmaz, Napa, CA (US);
Eugene A. Sprague, Helotes, TX (US);
Christopher E. Banas, Breckenridge, CO (US);
Assignee:
Vactronix Scientific, LLC, Fremont, CA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 2/07 (2013.01); A61F 2/82 (2013.01); A61F 2/91 (2013.01); A61F 2/915 (2013.01); A61F 2/00 (2006.01); A61L 27/36 (2006.01); A61L 27/04 (2006.01); A61L 27/50 (2006.01); A61L 31/02 (2006.01); A61F 2/90 (2013.01);
U.S. Cl.
CPC ...
A61F 2/07 (2013.01); A61F 2/0077 (2013.01); A61F 2/82 (2013.01); A61F 2/91 (2013.01); A61F 2/915 (2013.01); A61F 2/90 (2013.01); A61F 2002/0086 (2013.01); A61F 2002/072 (2013.01); A61F 2002/9155 (2013.01); A61F 2002/91541 (2013.01); A61F 2220/005 (2013.01); A61F 2220/0041 (2013.01); A61F 2220/0058 (2013.01); A61F 2220/0075 (2013.01); A61L 27/04 (2013.01); A61L 27/3679 (2013.01); A61L 27/507 (2013.01); A61L 31/022 (2013.01); Y10T 29/49936 (2015.01);
Abstract
An implantable medical device that is fabricated from materials that present a blood or body fluid or tissue contact surface that has controlled heterogeneities in material constitution. An endoluminal stent-graft and web-stent that is made of a monolithic material formed into differentiated regions defining structural members and web regions extending across interstitial spaces between the structural members. The endoluminal stent-graft is characterized by having controlled heterogeneities at the blood flow surface of the stent.